开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-08-14 ms3000000983513178 来自湖北省

02 Aug 2024 投的，
08 Aug 2024 with editor ，
13 Aug 2024 Decision in Process。
这是不是要拒的节奏啊

66 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-06-09 ms8000001555903844 来自辽宁省

被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗

89 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-08-23 研究牲小F 来自甘肃省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肾脏;药理学
经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-07-08 zhanghanluck 来自云南省

请问这个期刊对WB是什么要求

91 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-08-15 ms3000000197331596 来自天津

这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？

69 0

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-05-07 阜新学来自四川省

近期decision in process需要等多久啊，8天了没动静，有点着急

99 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-07-09 ms9000000336335389 来自广东省

请问现在一审后DIP多久啊，已经九天了

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-05-21 ms8000000941838223 来自北京

二审后DIP8天了，hope

97 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-07-06 ms8000001555903844 来自北京

一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊

94 0

[GetPortalCommentsPageByObjectIdResponse(id=2220021, encodeId=dfdc222002119, content=02 Aug 2024 投的， 08 Aug 2024 with editor ， 13 Aug 2024 Decision in Process。 这是不是要拒的节奏啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Wed Aug 14 08:48:13 CST 2024, time=2024-08-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2209165, encodeId=747e220916552, content=被拒稿但编辑建议修改后重新投稿，是可以继续再投是吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun Jun 09 22:53:52 CST 2024, time=2024-06-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2213810, encodeId=215622138101e, content=请问这个期刊对WB是什么要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1e025572785, createdName=zhanghanluck, createdTime=Mon Jul 08 01:52:41 CST 2024, time=2024-07-08, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2220327, encodeId=ab58222032e8e, content=这个杂志怎么样呀?为什么还掉区了呢，是因为年发文量太少了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fd95435962, createdName=ms3000000197331596, createdTime=Thu Aug 15 20:10:17 CST 2024, time=2024-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2202423, encodeId=0c9222024234c, content=近期decision in process需要等多久啊，8天了没动静，有点着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/1bc2b6041fd32dff415d57154925e27e.jpg, createdBy=e7265079447, createdName=阜新学, createdTime=Tue May 07 21:04:54 CST 2024, time=2024-05-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214073, encodeId=e2d022140e36f, content=请问现在一审后DIP多久啊，已经九天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70d29124933, createdName=ms9000000336335389, createdTime=Tue Jul 09 14:04:28 CST 2024, time=2024-07-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205902, encodeId=0ade220590282, content=二审后DIP8天了，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Tue May 21 19:54:33 CST 2024, time=2024-05-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213576, encodeId=083122135e69a, content=一审DIP要等多久啊？是不是一审under review 之后变DIP是要被拒啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat Jul 06 19:17:38 CST 2024, time=2024-07-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209267, encodeId=0069220926ee9, content=收中药单体的肿瘤研究吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Mon Jun 10 22:24:57 CST 2024, time=2024-06-10, status=1, ipAttribution=山东省)]

2024-06-10 Spiriting 来自山东省

收中药单体的肿瘤研究吗？

91 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务